About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Brca2tm1Cam
targeted mutation 1, University of Cambridge
MGI:1930616
Summary 9 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Brca2tm1Cam/Brca2tm1Cam 129S/SvEv-Brca2tm1Cam MGI:3831436
hm2
 		Brca2tm1Cam/Brca2tm1Cam involves: 129S/SvEv MGI:3831515
hm3
 		Brca2tm1Cam/Brca2tm1Cam involves: 129S/SvEv * MF1 MGI:3831435
cn4
 		Brca2tm1Brn/Brca2tm1Cam
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0 		involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N MGI:4940096
cn5
 		Brca2tm1Cam/Brca2tm1Brn
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0 		involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N MGI:4940102
cn6
 		Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+ 		involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N MGI:4940104
cn7
 		Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0 		involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB/N MGI:4940106
cn8
 		Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0 		involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N MGI:4940099
cn9
 		Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0 		involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N MGI:4940100


Genotype
MGI:3831436
hm1
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Cam
Genetic
Background		 129S/SvEv-Brca2tm1Cam
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
neonatal lethality, incomplete penetrance ( J:46812 )
• 90% of neonates are found dead
postnatal lethality, incomplete penetrance ( J:46812 )
• 50% of mice that are born alive die by weaning
prenatal lethality, incomplete penetrance ( J:46812 )
• fewer than expected mice are present at E10.5
• only 2.7% of the expected 25% are born alive

skeleton

growth/size/body
embryonic growth retardation ( J:46812 )

embryo




Genotype
MGI:3831515
hm2
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Cam
Genetic
Background		 involves: 129S/SvEv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
cellular
abnormal mitosis ( J:93261 )
• mouse embryonic fibroblasts (MEFs) exhibit an extended time spent in anapahse compared to wild-type cells
• binucleated MEFs are more frequent than in wild-type cells
• completion of cytokinesis in MEFs is impaired compared to in wild-type cells




Genotype
MGI:3831435
hm3
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Cam
Genetic
Background		 involves: 129S/SvEv * MF1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:46812 )
• all mice that survive weaning develop and die of thymic lymphomas between 12 and 14 weeks of age
perinatal lethality, incomplete penetrance ( J:46812 )
• only 11.2% of the expected 25% are born alive
neonatal lethality, incomplete penetrance ( J:46812 )
• 90% of neonates are found dead
postnatal lethality, incomplete penetrance ( J:46812 )
• 50% of mice that are born alive die by weaning
embryonic lethality during organogenesis, incomplete penetrance ( J:46812 )
• fewer than expected mice are present at E10.5

reproductive system
absent germ cells ( J:46812 )
• adult males and females lack germ cells

neoplasm
increased T cell derived lymphoma incidence ( J:46812 )
• all mice that survive weaning develop and die of thymic lymphomas between 12 and 14 weeks of age
• thymic tumors disrupt the cortical-medullary structure of the thymus with monomorphic lymphoblastic cells
• tumor infiltrate in the lungs is observed in mice with thymic lymphomas

skeleton

immune system
increased thymus weight ( J:46812 )
• thymic weight is double wild-type
increased T cell derived lymphoma incidence ( J:46812 )
• all mice that survive weaning develop and die of thymic lymphomas between 12 and 14 weeks of age
• thymic tumors disrupt the cortical-medullary structure of the thymus with monomorphic lymphoblastic cells
• tumor infiltrate in the lungs is observed in mice with thymic lymphomas

growth/size/body
embryonic growth retardation ( J:46812 )

hematopoietic system
increased thymus weight ( J:46812 )
• thymic weight is double wild-type
increased T cell derived lymphoma incidence ( J:46812 )
• all mice that survive weaning develop and die of thymic lymphomas between 12 and 14 weeks of age
• thymic tumors disrupt the cortical-medullary structure of the thymus with monomorphic lymphoblastic cells
• tumor infiltrate in the lungs is observed in mice with thymic lymphomas

embryo

endocrine/exocrine glands
increased thymus weight ( J:46812 )
• thymic weight is double wild-type
increased T cell derived lymphoma incidence ( J:46812 )
• all mice that survive weaning develop and die of thymic lymphomas between 12 and 14 weeks of age
• thymic tumors disrupt the cortical-medullary structure of the thymus with monomorphic lymphoblastic cells
• tumor infiltrate in the lungs is observed in mice with thymic lymphomas

cellular
absent germ cells ( J:46812 )
• adult males and females lack germ cells




Genotype
MGI:4940096
cn4
Allelic
Composition		 Brca2tm1Brn/Brca2tm1Cam
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Brn mutation (5 available); any Brca2 mutation (132 available)
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (240 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased pancreatic acinar cell carcinoma incidence ( J:166678 )
• about 18% of assessable tumor cases develop an acinar-cell carcinoma component of pancreatic tumors
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• high penetrance (29 of 30 mutants) of pancreatic ductal adenocarcinomas

mortality/aging
premature death ( J:166678 )
• average survival time is 84 days, with a range of 48-110 days

endocrine/exocrine glands
increased pancreatic acinar cell carcinoma incidence ( J:166678 )
• about 18% of assessable tumor cases develop an acinar-cell carcinoma component of pancreatic tumors
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• high penetrance (29 of 30 mutants) of pancreatic ductal adenocarcinomas

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
pancreatic carcinoma DOID:4905 OMIM:260350
 J:166678




Genotype
MGI:4940102
cn5
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Brn
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Brn mutation (5 available); any Brca2 mutation (132 available)
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
digestive/alimentary system
exocrine pancreatic insufficiency ( J:166678 )
• pancreatic insufficiency; spectrum of anomalies are seen from isolated paucity of the islets of Langerhans to complete fibro-inflammatory or cystic degeneration of both the endocrine and exocrine pancreas

endocrine/exocrine glands
increased pancreas apoptosis ( J:166678 )
• pancreata from 6 day old mutants exhibits an increase in apoptotic cells compared to controls
exocrine pancreatic insufficiency ( J:166678 )
• pancreatic insufficiency; spectrum of anomalies are seen from isolated paucity of the islets of Langerhans to complete fibro-inflammatory or cystic degeneration of both the endocrine and exocrine pancreas
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• mutants not succumbing to pancreatic insufficiency later develop pancreatic ductal adenocarcinomas with a moderate latency and incomplete penetrance (6 of 32 mutants)

mortality/aging
premature death ( J:166678 )
• mutants exhibit shortened pancreatic ductal adenocarcinoma-free survival

neoplasm
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• mutants not succumbing to pancreatic insufficiency later develop pancreatic ductal adenocarcinomas with a moderate latency and incomplete penetrance (6 of 32 mutants)

cellular
increased pancreas apoptosis ( J:166678 )
• pancreata from 6 day old mutants exhibits an increase in apoptotic cells compared to controls




Genotype
MGI:4940104
cn6
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+
Genetic
Background		 involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Brn mutation (5 available); any Brca2 mutation (132 available)
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (240 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
digestive/alimentary system
exocrine pancreatic insufficiency ( J:166678 )
• pancreatic insufficiency is occasionally observed in mutants

endocrine/exocrine glands
exocrine pancreatic insufficiency ( J:166678 )
• pancreatic insufficiency is occasionally observed in mutants

mortality/aging
premature death ( J:166678 )
• premature death before 600 days of age due to lymphoid malignancies and sarcomas

neoplasm
increased malignant tumor incidence ( J:166678 )
• mutants develop lymphoid malignancies




Genotype
MGI:4940106
cn7
Allelic
Composition		 Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Brn mutation (5 available); any Brca2 mutation (132 available)
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
digestive/alimentary system
exocrine pancreatic insufficiency ( J:166678 )
• small fraction of mutants develop pancreatic insufficiency

endocrine/exocrine glands
exocrine pancreatic insufficiency ( J:166678 )
• small fraction of mutants develop pancreatic insufficiency

mortality/aging
premature death ( J:166678 )
• premature death in the small fraction of mutants with pancreatic insufficiency




Genotype
MGI:4940099
cn8
Allelic
Composition		 Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
Genetic
Background		 involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (240 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• 26 of 30 mutants develop pancreatic ductal adenocarcinomas

mortality/aging
premature death ( J:166678 )
• average survival time is 143 days, with a range of 91-191 days

endocrine/exocrine glands
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• 26 of 30 mutants develop pancreatic ductal adenocarcinomas




Genotype
MGI:4940100
cn9
Allelic
Composition		 Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Genetic
Background		 involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca2tm1Cam mutation (0 available); any Brca2 mutation (132 available)
Krastm4Tyj mutation (9 available); any Kras mutation (84 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• 12 of 40 mutants develop pancreatic ductal adenocarcinomas

mortality/aging
premature death ( J:166678 )
• reduction in pancreatic ductal adenocarcinoma-free survival

endocrine/exocrine glands
increased pancreatic ductal adenocarcinoma incidence ( J:166678 )
• 12 of 40 mutants develop pancreatic ductal adenocarcinomas




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory